OTC triptans market research

Euromonitor has the world’s most comprehensive research on the OTC triptans category within the consumer health industry. We monitor and analyse industry trends around the world, including in-depth data on market share and market size – from the “big picture” qualitative analysis; down to specific category data.

Euromonitor data and market analysis cultivates your organization’s awareness of the OTC triptans market and the greater competitive environment, ensuring accurate and focused strategies for your business.

A resource for your entire organization, Euromonitor market research supports every level of business, assisting in strategic development, marketing, mergers and acquisitions, and brand management.

Our OTC triptans market research answer questions such as:

What is the market size of OTC triptans?
What are the major brands in OTC triptans?
What are the major brands in OTC triptans?
Are OTC triptans legally available?
How many generations of triptans are sold?

Filter Results

Total: (8)

by Product Type
- Reports (8)
  - Country Reports (7)
  - Company Profiles (1)
by Geography
by Date
- Last Year (7)
- More than a Year (1)

Country Report

OTC Triptans in Sweden

The growing self-medication trend is a key driver of category sales. OTC triptans are most likely to be purchased by consumers who believe they are suffering from a migraine but who have not been diagnosed by a medical professional as such.

Jul 2011 | $900| Add to cart | View details ›

Country Report

OTC Triptans in New Zealand

OTC triptans were first available in New Zealand in 2007, after being approved by Medsafe in 2006. The category saw rapid growth of 110% in 2008, a significantly reduced 20% increase in 2009, and a 15% rise in 2010. As the majority of triptans in New...

May 2011 | $900| Add to cart | View details ›

Country Report

OTC Triptans in the United Kingdom

In 2010 sales of OTC triptans were worth approaching £5 million, up 35% in current terms on 2009. Migraines already affect 15% of adults in the UK, equivalent to almost six million people, and with people’s lives becoming increasingly stressful, ...

Apr 2011 | $900| Add to cart | View details ›

Country Report

OTC Triptans in Germany

The high cost of OTC triptans is a factor that discourages widespread usage in Germany. For example, two Naratriptan tablets cost around €10 through brick and mortar chemists/pharmacists and about €5 through some online pharmacies due to special ...

Apr 2011 | $900| Add to cart | View details ›

Country Report

OTC Triptans in the Czech Republic

OTC triptans are currently only available via prescription in the Czech Republic and there are no indications that such products will be made available OTC in the foreseeable future.

Mar 2011 | $900| Add to cart | View details ›

Country Report

OTC Triptans in Estonia

Triptans are only available as Rx medicines in Estonia. Triptans that are prescribed include Zolmitriptan Actavis 5mg (produced by Actavis Ltd), Imigran (produced by GlaxoSmithKline Ltd), Sumatriptan Sandoz (produced by Sandoz) and Cinie (produced by...

Feb 2011 | $900| Add to cart | View details ›

Country Report

OTC Triptans in Russia

There are no available OTC Triptans in Russia. All medicines are Rx only.

Feb 2011 | $900| Add to cart | View details ›

Company Profile

Merck KGaA in Consumer Health

This report analyses Merck KGaA’s consumer health operations. It particularly focuses on the company’s actual and potential strategic responses to the challenges deriving from market consolidation and on the most effective target markets for the ...

Jun 2010 | $525| Add to cart | View details ›